Home
>
National Drug Code (NDC)
>
Fludarabine phosphate
Fludarabine phosphate - 25021-205-05 - (Fludarabine phosphate)
Drug Information of Fludarabine phosphate
| Product NDC: | 25021-205 |
| Proprietary Name: | Fludarabine phosphate |
| Non Proprietary Name: | Fludarabine phosphate |
| Active Ingredient(s): | 50 mg/2mL & nbsp; Fludarabine phosphate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fludarabine phosphate
| Product NDC: | 25021-205 |
| Labeler Name: | Sagent Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078610 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090201 |
Package Information of Fludarabine phosphate
| Package NDC: | 25021-205-05 |
| Package Description: | 1 VIAL in 1 CARTON (25021-205-05) > 2 mL in 1 VIAL |
NDC Information of Fludarabine phosphate
| NDC Code | 25021-205-05 |
| Proprietary Name | Fludarabine phosphate |
| Package Description | 1 VIAL in 1 CARTON (25021-205-05) > 2 mL in 1 VIAL |
| Product NDC | 25021-205 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fludarabine phosphate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090201 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceutical, Inc. |
| Substance Name | FLUDARABINE PHOSPHATE |
| Strength Number | 50 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
